Repurposing Drugs, and Fresh Outcomes from Other Familiar Sources

Abstract

In the face of new and emerging infectious disease threats, it is prudent to look back at old or even ancient sources to uncover a drug or entity that might work anew or in a different context, according to several researchers who spoke during the 2016 ASM Biodefense and Emerging Diseases Research Meeting last February. Here, let us consider the old in three specific ways: revisiting licensed drugs, using old phage for new purposes, and looking at old beasts for new antimicrobials.